Press releases | Finanzwire

PRESS RELEASE

published on 10/29/2025 at 14:03, 3 months 7 days ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
The Vanguard Group, Inc. discloses a 10.60% interest in Qualcomm Incorporated as per Form 8.3 filing

Securities Form 8.3 Disclosure The Vanguard Group Qualcomm Incorporated
PRESS RELEASE

published on 10/29/2025 at 14:02, 3 months 7 days ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
The Vanguard Group, Inc. discloses 5.67% ownership in Avadel Pharmaceuticals plc as of 28 October 2025

The Vanguard Group, Inc. Form 8.3 IRSH Ownership Disclosure Avadel Pharmaceuticals Plc
PRESS RELEASE

published on 10/29/2025 at 14:00, 3 months 7 days ago

Mallia Will Pitch as Falling Walls Finalist, Heads to BIO-Europe Ahead of Upcoming Product Launch
Mallia Innovations to pitch at Falling Walls as finalist & attend BIO-Europe before product launch. Company focuses on hair loss therapies & cosmetic applications of sCD83 protein

Cosmetic Applications BIO-Europe Mallia Innovations Falling Walls Hair Loss Therapies
PRESS RELEASE

published on 10/29/2025 at 14:00, 3 months 7 days ago

OHB SE completes full takeover of MT Aerospace AG
OHB SE completes full takeover of MT Aerospace AG, becoming the sole shareholder. The acquisition strengthens OHB's position in the aerospace and defense industry

OHB SE Takeover Aerospace Defense MT Aerospace AG
PRESS RELEASE

published on 10/29/2025 at 14:00, 3 months 7 days ago

FRP Holdings, Inc. Announces Release Date for Its 2025 Third Quarter Earnings and Details for the Earnings Conference Call
FRP Holdings, Inc. to release Q3 earnings on Nov 5, 2025. Conference call on Nov 6, 2025. Details for live call and replay provided. Company's real estate business operations outlined

Conference Call Investors Real Estate Earnings FRP Holdings
PRESS RELEASE

published on 10/29/2025 at 14:00, 3 months 7 days ago

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date
Revelation Biosciences cancels Special Meeting of Stockholders due to technical difficulty, sets new date. Focus on rebalancing inflammation with Gemini formulation

Special Meeting Stockholders Inflammation Revelation Biosciences Gemini Formulation
PRESS RELEASE

published on 10/29/2025 at 13:47, 3 months 7 days ago

EQS-Adhoc: PSI expects higher one-time expenses in fiscal year 2025
PSI Software SE expects higher one-time expenses in fiscal year 2025 due to transaction costs related to an investment agreement with Warburg Pincus. Company anticipates growth in order intake and sales for the year

Growth PSI Software SE Investment Agreement Fiscal Year 2025 One-time Expenses
PRESS RELEASE

published on 10/29/2025 at 13:45, 3 months 7 days ago

Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive
NanoViricides, Inc. announced progress in antiviral research with their drug NV-387 showing potent activity against Measles virus. Clinical trials have shown safety and effectiveness, positioning for emergency use

NanoViricides NV-387 Clinical Trials Antiviral Research Measles Virus
PRESS RELEASE

published on 10/29/2025 at 13:15, 3 months 7 days ago

Circus successfully launches its autonomous AI robotics system CA-1 in REWE supermarkets
Circus SE launches autonomous AI robotics system CA-1 in REWE supermarkets, revolutionizing meal production with 'Fresh & Smart' brand integrated by REWE West

Circus SE Meal Production REWE Supermarkets Autonomous AI Robotics Fresh & Smart
PRESS RELEASE

published on 10/29/2025 at 13:00, 3 months 7 days ago

DEBRA Research Invests in Eliksa Therapeutics to Advance ELK-003, a Biological Eye Drop for Epidermolysis Bullosa-Related Ocular Complications
DEBRA Research invests in Eliksa Therapeutics to advance ELK-003, a biological eye drop for Epidermolysis Bullosa-related ocular complications, supported by a syndicate of mission-driven organizations

Rare Diseases Ocular Complications DEBRA Research Eliksa Therapeutics ELK-003

Published on 02/06/2026 at 00:57, 6 hours 9 minutes ago

Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 7 hours 6 minutes ago

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 7 hours 51 minutes ago

Amarc Further Expands Its Toodoggone Technical Team
Published on 02/05/2026 at 23:00, 8 hours 6 minutes ago

Grounded People Announces Non-Brokered Private Placement and Strategic Review
Published on 02/05/2026 at 21:00, 10 hours 6 minutes ago

Kidoz Welcomes CloudX Innovation Driving Fairer Mobile Advertising Auctions

View all ACCESSWIRE

Published on 02/06/2026 at 06:30, 35 minutes ago

LEM reports stable sales in first nine months 2025/26
Published on 02/06/2026 at 06:05, 1 hour ago

Driven by Chairman Junhyuk Bang's Visionary Leadership, Coway Announces Financial Results for Q4 and FY2025
Published on 02/06/2026 at 05:50, 1 hour 15 minutes ago

CGTN: Xi Jinping's same-day calls with Putin and Trump underscore China's role in global stability
Published on 02/05/2026 at 19:27, 11 hours 38 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 12 hours 19 minutes ago

EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025

View all EQS

Published on 02/05/2026 at 19:24, 11 hours 41 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 12 hours 41 minutes ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 12 hours 59 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
Published on 02/05/2026 at 18:00, 13 hours 6 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of January 30, 2026
Published on 02/05/2026 at 18:00, 13 hours 6 minutes ago

ACM - Press release 2025 results

View all LES ECHOS COMFI WIRE

News